Fund shareholders of Ideaya Biosciences Inc
ISIN US45166A1025 · United States · LEI 549300ULW08F62IJML11
- Fund shareholders
- 262
- Of which ETFs
- 57 205 other funds
- Value held
- ≈ 1.4B $ 1.4B $ · 47.8M SEK · 344K €
- Share of capital
- 40.8 % of 96.5M shares on Jul 31, 2026
262 funds hold this company. This table lists the 260 that declare it in a regulatory filing. The other 2 publish their holdings in their own reports. The “Fund reports” tab lists them, with their weight.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VY(R) JPMORGAN SMALL CAP CORE EQUITY PORTFOLIO Voya Investors Trust | 3,472 | 129.4K $ | 0.04 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 3,303 | 97.3K $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 3,246 | 95.7K $ | 0.13 % | 0.00 % | as of May 31, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 3,151 | 92.9K $ | 0.03 % | 0.00 % | as of May 31, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 3,117 | 91.9K $ | 0.04 % | 0.00 % | as of May 31, 2026 ↗ |
| AVIP AB Mid Cap Core Portfolio AuguStar Variable Insurance Products Fund Inc | 3,077 | 114.7K $ | 0.11 % | 0.00 % | as of Jun 30, 2026 ↗ |
| BNY Mellon US Small Cap Core Equity ETF BNY Mellon ETF Trust | 3,052 | 108.3K $ | 0.12 % | 0.00 % | as of Jul 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF SPDR INDEX SHARES FUNDS | 3,001 | 111.8K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PGIM Quant Solutions Small-Cap Value Fund Target Portfolio Trust | 3,000 | 106.5K $ | 0.02 % | 0.00 % | as of Jul 31, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 2,944 | 109.7K $ | 0.04 % | 0.00 % | as of Jun 30, 2026 ↗ |
| AVIP BlackRock Advantage Small Cap Growth Portfolio AuguStar Variable Insurance Products Fund Inc | 2,707 | 100.9K $ | 0.07 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Columbia Integrated Small Cap Growth Fund Columbia Funds Series Trust II | 2,625 | 77.4K $ | 0.24 % | 0.00 % | as of May 31, 2026 ↗ |
| Dimensional US Vector Equity ETF Dimensional ETF Trust | 2,603 | 92.4K $ | 0.02 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Tax-Aware Overlay A Portfolio BERNSTEIN SANFORD C FUND INC | 2,382 | 88.8K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 2,360 | 88K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 2,273 | 84.7K $ | 0.09 % | 0.00 % | as of Jun 30, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 2,141 | 79.8K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 2,117 | 78.9K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Goldman Sachs Small Cap Growth Insights Fund Goldman Sachs Trust | 2,071 | 73.5K $ | 0.02 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 1,999 | 71K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 1,989 | 58.6K $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
| Venerable US Small Cap Fund Venerable Variable Insurance Trust | 1,988 | 74.1K $ | 0.05 % | 0.00 % | as of Jun 30, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 1,780 | 66.3K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 1,380 | 51.4K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| EQ/Morgan Stanley Small Cap Growth Portfolio EQ Advisors Trust | 1,268 | 47.3K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 1,134 | 42.3K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| SA Multi-Managed Small Cap Portfolio SEASONS SERIES TRUST | 1,114 | 41.5K $ | 0.03 % | 0.00 % | as of Jun 30, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 1,080 | 38.3K $ | 0.07 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Pacer WealthShield ETF Pacer Funds Trust | 1,071 | 38K $ | 0.16 % | 0.00 % | as of Jul 31, 2026 ↗ |
| SIIT MULTI-ASSET REAL RETURN FUND SEI INSTITUTIONAL INVESTMENTS TRUST | 1,035 | 30.5K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| SA T. Rowe Price Allocation Moderately Aggressive Portfolio SUNAMERICA SERIES TRUST | 1,003 | 35.6K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Overlay A Portfolio BERNSTEIN SANFORD C FUND INC | 975 | 36.3K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Avantis U.S. Equity Fund American Century ETF Trust | 880 | 25.9K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 870 | 30.9K $ | 0.17 % | 0.00 % | as of Jul 31, 2026 ↗ |
| SIMT Multi-Asset Inflation Managed Fund SEI INSTITUTIONAL MANAGED TRUST | 752 | 28K $ | 0.01 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PD Small-Cap Growth Index Portfolio PACIFIC SELECT FUND | 750 | 28K $ | 0.02 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Corgi Genomics & Precision Medicine ETF Corgi ETF Trust I | 682 | 25.4K $ | 1.49 % | 0.00 % | as of Jun 30, 2026 ↗ |
| T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. | 606 | 22.6K $ | 0.12 % | 0.00 % | as of Jun 30, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 522 | 19.5K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Innovator U.S. Small Cap Managed 10 Buffer ETF Innovator ETFs Trust | 491 | 17.4K $ | 0.16 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 489 | 17.4K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 451 | 16.8K $ | 0.02 % | 0.00 % | as of Jun 30, 2026 ↗ |
| AZL DFA U.S. Core Equity Fund Allianz Variable Insurance Products Trust | 449 | 16.7K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 1 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 359 | 13.4K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 345 | 12.9K $ | 0.06 % | 0.00 % | as of Jun 30, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 225 | 8.4K $ | 0.07 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 217 | 8.1K $ | 0.00 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 208 | 7.8K $ | 0.05 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 124 | 4.6K $ | 0.06 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Enhanced Small Cap Growth ETF Fidelity Covington Trust | 104 | 3.9K $ | 0.07 % | 0.00 % | as of Jun 30, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 100 | 3.6K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 97 | 3.6K $ | 0.10 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Morningstar Alternatives Fund Morningstar Funds Trust | 80 | 2.8K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 79 | 2.3K $ | 0.01 % | 0.00 % | as of May 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 71 | 2.5K $ | 0.03 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Goldman Sachs MSCI World Private Equity Return Tracker ETF Goldman Sachs ETF Trust | 30 | 884.1 $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 25 | 736.8 $ | 0.06 % | 0.00 % | as of May 31, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 24 | 894.5 $ | 0.02 % | 0.00 % | as of Jun 30, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 294.2K € | 0.36 % | as of Dec 31, 2025 ↗ | ||
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 49.8K € | 1.36 % | as of Dec 31, 2025 ↗ |
Funds that publish their own holdings
| Fund | Weight in fund | |
|---|---|---|
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 1.06 % | as of Sep 30, 2025 ↗ |
| BNP Paribas Funds Health Care Innovators BNP Paribas Asset Management Luxembourg | 0.67 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| iShares Genomics Immunology and Healthcare ETF iShares Trust | 3.36 % | as of Jul 31, 2026 ↗ |
| Tema Oncology ETF Tema ETF Trust | 2.27 % | as of May 31, 2026 ↗ |
| NYLIM Fiera SMID Growth Fund NYLIM FUNDS TRUST | 1.82 % | as of Jul 31, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 1.65 % | as of May 31, 2026 ↗ |
| Jacob Small Cap Growth Fund Jacob Funds Inc. | 1.58 % | as of May 31, 2026 ↗ |
| Jacob Discovery Fund Jacob Funds Inc. | 1.53 % | as of May 31, 2026 ↗ |
| Corgi Genomics & Precision Medicine ETF Corgi ETF Trust I | 1.49 % | as of Jun 30, 2026 ↗ |
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 1.36 % | as of Dec 31, 2025 ↗ |
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 1.30 % | as of Mar 31, 2026 ↗ |
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 1.06 % | as of Sep 30, 2025 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 255 | +17 | 39,182,795 | +11.4 % |
| 2026Q2 | 238 | +21 | 35,159,196 | -3.8 % |
| 2026Q1 | 217 | +23 | 36,533,251 | +1.4 % |
| 2025Q4 | 194 | +10 | 36,025,546 | -5.7 % |
| 2025Q3 | 184 | -7 | 38,196,568 | +4.7 % |
| 2025Q2 | 191 | +1 | 36,475,441 | -0.5 % |
| 2025Q1 | 190 | -22 | 36,664,318 | -1.2 % |
| 2024Q4 | 212 | -19 | 37,110,931 | +10.2 % |
| 2024Q3 | 231 | +1 | 33,674,543 | +5.9 % |
| 2024Q2 | 230 | +24 | 31,787,524 | +25.6 % |
| 2024Q1 | 206 | +9 | 25,306,229 | +28.6 % |
| 2023Q4 | 197 | 19,676,904 |
Institutional managers
246 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 13,172,103 | 438.9M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 8,442,133 | 281.3M $ | as of Mar 31, 2026 |
| JANUS HENDERSON GROUP PLC | 7,265,253 | 242M $ | as of Mar 31, 2026 |
| Capital Research Global Investors | 5,163,543 | 172M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 3,946,515 | 131.5M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 3,781,167 | 126M $ | as of Mar 31, 2026 |
| Logos Global Management LP | 3,450,000 | 115M $ | as of Mar 31, 2026 |
| FEDERATED HERMES, INC. | 2,987,107 | 99.5M $ | as of Mar 31, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,823,500 | 94.1M $ | as of Mar 31, 2026 |
| Fiera Capital Corp | 2,527,076 | 84.2M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,500,724 | 83.3M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,860,453 | 62M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,655,617 | 55.2M $ | as of Mar 31, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 1,530,008 | 51M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 1,333,478 | 44.4M $ | as of Mar 31, 2026 |
| GSK plc | 1,333,333 | 44.4M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,315,869 | 43.8K $ | as of Mar 31, 2026 |
| Sofinnova Investments, Inc. | 1,131,786 | 37.7M $ | as of Mar 31, 2026 |
| Candriam S.C.A. | 1,107,708 | 36.9M $ | as of Mar 31, 2026 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1,101,145 | 36.7M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 942,091 | 31.4M $ | as of Mar 31, 2026 |
| Ensign Peak Advisors, Inc | 899,504 | 30M $ | as of Mar 31, 2026 |
| Fisher Asset Management, LLC | 882,699 | 29.4M $ | as of Mar 31, 2026 |
| First Turn Management, LLC | 873,838 | 29.1M $ | as of Mar 31, 2026 |
| UBS Group AG | 762,548 | 25.4M $ | as of Mar 31, 2026 |
Declared shareholders of Ideaya Biosciences Inc
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Baker Bros. Advisors LP and 3 others | 5.20 % | 5,010,030 | as of Jun 30, 2026 · SCHEDULE 13G |
| Vanguard Capital Management | 5.08 % | 4,834,771 | as of Jun 30, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Ideaya Biosciences Inc". https://titelia.com/en/stocks/ideaya-biosciences-inc-US45166A1025